Data / Form D filings / Zivo Bioscience, Inc.
Zivo Bioscience, Inc.: Form D filings
Zivo Bioscience, Inc., a biotechnology company in Bloomfield Hills, MI, filed 51 Form D notices with the SEC between 2009 and 2023. The latest, on July 17, 2023, reports $4 million sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI, 48304
- Phone
- (248) 452-9866
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1101026
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2023 | New notice | $3,999,960 | $3,999,960 | 1 | Jun 30, 2023 | sec.gov | |
| May 15, 2018 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Oct 14, 2016 | New notice | $5,000,000 | $1,250,000 | $3,750,000 | 6 | Sep 30, 2016 | sec.gov |
| Mar 28, 2014 | New notice | $100,000 | $100,000 | 1 | Mar 27, 2014 | sec.gov | |
| Dec 24, 2013 | New notice | $250,000 | $250,000 | 1 | Dec 20, 2013 | sec.gov | |
| Dec 23, 2013 | New notice | $500,000 | $375,000 | $125,000 | 1 | Dec 17, 2013 | sec.gov |
| Aug 26, 2013 | New notice | $132,000 | $132,000 | 5 | Aug 21, 2013 | sec.gov | |
| Aug 12, 2013 | New notice | $325,000 | $325,000 | 5 | Jul 31, 2013 | sec.gov | |
| Jan 7, 2013 | New notice | $35,000 | $35,000 | 1 | Dec 31, 2012 | sec.gov | |
| Dec 27, 2012 | New notice | $50,000 | $50,000 | 1 | Sep 19, 2012 | sec.gov | |
| Dec 26, 2012 | New notice | $140,000 | $140,000 | 1 | Sep 11, 2012 | sec.gov | |
| Jul 27, 2012 | New notice | $62,500 | $62,500 | 1 | Jul 16, 2012 | sec.gov | |
| Jul 27, 2012 | New notice | $62,500 | $62,500 | 1 | Jul 13, 2012 | sec.gov | |
| May 24, 2012 | New notice | $300,000 | $300,000 | 1 | May 10, 2012 | sec.gov | |
| May 14, 2012 | Amendment | $2,000,000 | $1,025,000 | $975,000 | 1 | Dec 2, 2011 | sec.gov |
| Apr 17, 2012 | Amendment | $2,000,000 | $775,000 | $1,225,000 | 1 | Dec 2, 2011 | sec.gov |
| Apr 10, 2012 | Amendment | $500,000 | $395,708 | $104,292 | 1 | Jan 27, 2012 | sec.gov |
| Mar 26, 2012 | Amendment | $2,000,000 | $700,000 | $1,300,000 | 1 | Dec 2, 2011 | sec.gov |
| Feb 13, 2012 | Amendment | $500,000 | $332,000 | $168,000 | 1 | Jan 27, 2012 | sec.gov |
| Feb 10, 2012 | Amendment | $500,000 | $332,000 | $168,000 | 1 | Jan 27, 2012 | sec.gov |
| Dec 12, 2011 | New notice | $2,000,000 | $600,000 | $1,400,000 | 1 | Dec 2, 2011 | sec.gov |
| Dec 9, 2011 | New notice | $2,500,000 | $278,000 | $2,222,000 | 1 | Nov 25, 2011 | sec.gov |
| Nov 14, 2011 | New notice | $500,000 | $100,000 | $400,000 | 1 | Nov 1, 2011 | sec.gov |
| Sep 2, 2011 | Amendment | $400,000 | $290,500 | $109,500 | 7 | Feb 2, 2011 | sec.gov |
| Jul 28, 2011 | Amendment | $400,000 | $256,500 | $143,500 | 7 | Feb 2, 2011 | sec.gov |
| Jun 30, 2011 | Amendment | $400,000 | $156,500 | $243,500 | 7 | Feb 2, 2011 | sec.gov |
| Jun 10, 2011 | Amendment | $400,000 | $142,500 | $257,500 | 7 | Feb 2, 2011 | sec.gov |
| Jun 1, 2011 | Amendment | $1,800,000 | $1,717,128 | $82,872 | 43 | Sep 14, 2009 | sec.gov |
| Apr 21, 2011 | Amendment | $400,000 | $122,500 | $277,500 | 7 | Feb 2, 2011 | sec.gov |
| Mar 3, 2011 | Amendment | $1,800,000 | $1,707,128 | $92,872 | 43 | Sep 14, 2009 | sec.gov |
| Feb 14, 2011 | Amendment | $1,800,000 | $1,627,128 | $172,872 | 43 | Sep 14, 2009 | sec.gov |
| Feb 14, 2011 | Amendment | $400,000 | $112,500 | $287,500 | 6 | Feb 2, 2011 | sec.gov |
| Feb 11, 2011 | New notice | $400,000 | $112,500 | $287,500 | 6 | Feb 2, 2011 | sec.gov |
| Feb 1, 2011 | Amendment | $1,800,000 | $1,627,128 | $172,872 | 43 | Sep 14, 2009 | sec.gov |
| Oct 1, 2010 | Amendment | $1,800,000 | $1,547,128 | $252,872 | 42 | Sep 14, 2009 | sec.gov |
| Sep 8, 2010 | Amendment | $1,800,000 | $1,482,128 | $317,872 | 42 | Sep 14, 2009 | sec.gov |
| Aug 6, 2010 | Amendment | $1,800,000 | $1,457,128 | $342,872 | 41 | Sep 14, 2009 | sec.gov |
| Jul 21, 2010 | Amendment | $1,800,000 | $1,407,128 | $392,872 | 39 | Sep 14, 2009 | sec.gov |
| Jun 3, 2010 | Amendment | $1,800,000 | $1,389,628 | $410,372 | 38 | Sep 14, 2009 | sec.gov |
| May 20, 2010 | Amendment | $1,800,000 | $1,289,628 | $510,372 | 37 | Sep 14, 2009 | sec.gov |
| Apr 28, 2010 | Amendment | $1,800,000 | $1,239,628 | $560,372 | 35 | Sep 14, 2009 | sec.gov |
| Apr 28, 2010 | New notice | $675,000 | $675,000 | 1 | Apr 24, 2010 | sec.gov | |
| Apr 6, 2010 | Amendment | $1,800,000 | $1,084,628 | $715,372 | 31 | Sep 14, 2009 | sec.gov |
| Mar 16, 2010 | Amendment | $1,800,000 | $982,962 | $817,038 | 26 | Sep 14, 2009 | sec.gov |
| Mar 16, 2010 | Amendment | $1,800,000 | $982,962 | $817,038 | 26 | Sep 14, 2009 | sec.gov |
| Feb 19, 2010 | Amendment | $1,800,000 | $605,500 | $1,194,500 | 14 | Sep 14, 2009 | sec.gov |
| Feb 4, 2010 | Amendment | $1,800,000 | $569,500 | $1,230,500 | 11 | Sep 14, 2009 | sec.gov |
| Dec 17, 2009 | Amendment | $1,800,000 | $524,000 | $1,276,000 | 10 | Sep 14, 2009 | sec.gov |
| Nov 19, 2009 | Amendment | $1,800,000 | $500,000 | $1,300,000 | 10 | Sep 14, 2009 | sec.gov |
| Oct 13, 2009 | Amendment | $1,800,000 | $335,000 | $1,465,000 | 3 | Sep 14, 2009 | sec.gov |
| Sep 21, 2009 | New notice | $1,800,000 | $205,000 | $1,595,000 | 3 | Sep 14, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allison A. Cornell | Director | |
| Nola E. Masterson | Director | |
| Christopher D. Maggiore | Director | |
| John B. Payne | Executive Officer | |
| Keith R. Marchiando | Executive Officer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Zivo Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.